Women are reluctant to participate in trials despite being more likely to die of heart disease
There are extra barriers to recruiting women for cardiovascular research, even though more women die of heart disease than men, a new study shows.
Despite agreement that it is crucial to have proportional representation of both sexes in medical research, a recent review of 740 completed cardiovascular clinical trials conducted between 2010 and 2017 found that women account for roughly 38% of the total participants.
